Mice bearing KP1 TAS1440 tumors also showed a better response to anti–PD-L1 therapy alone, with a significant reduction in average tumor volume, compared with untreated KP1 TAS1440 tumor–bearing mice (Supplemental Figure 11C). The gene discussed is CD274; the disease is neoplasm.